Eclipse Regenesis

Eclipse Regenesis is the first developer of restorative therapies for pediatric and adult short bowel syndrome (SBS), focusing on harnessing the body's own tissue regeneration capabilities to treat critical diseases. Its flagship product, the Eclipse XL1 System™, aims to grow healthy intestines by 2-3 times within 2-3 weeks using a fully mechanical and repeatable method. Backed by over 15 years of scientific research and supported by SBS thought leaders from around the world, the Eclipse Regenesis team is passionate about pioneering a restorative therapy for a currently incurable disease state. The Eclipse XL1 System is a therapeutic device and is not commercially available in any region.